DIAGNOS Announces Closing of Second and Final Tranche of Private Placement
March 22, 2024 16:16 ET
|
DIAGNOS Inc.
BROSSARD, Quebec, March 22, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS Announces Grant of Stock Options
March 04, 2024 15:45 ET
|
DIAGNOS Inc.
BROSSARD, Quebec, March 04, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS annonce l'octroi d'options d'achat d'actions
March 04, 2024 15:45 ET
|
DIAGNOS inc.
BROSSARD, Québec, 04 mars 2024 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un pionnier dans le dépistage précoce de...
DIAGNOS Welcomes Mr. Michael Braeuel to its Board of Directors
February 29, 2024 11:10 ET
|
DIAGNOS Inc.
BROSSARD, Quebec, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS souhaite la bienvenue à M. Michael Braeuel au sein de son conseil d'administration
February 29, 2024 11:10 ET
|
DIAGNOS inc.
BROSSARD, Québec, 29 févr. 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), une pionnière de la détection précoce des...
DIAGNOS Announces Closing of First Tranche of Private Placement
February 27, 2024 16:13 ET
|
DIAGNOS Inc.
BROSSARD, Quebec, Feb. 27, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
Draper vill förbättra ECMO-behandling med CHS™-coatad produkt
February 27, 2024 04:03 ET
|
Corline Biomedical AB
Draper (The Charles Stark Draper Laboratory Inc.) meddelar att man ingått i partnerskap med US Department of Health and Human Services för att utveckla en innovativ produkt för behandling av akut...
Diagnos Announces Variation in One Insider Ownership of Common Shares
February 23, 2024 15:50 ET
|
DIAGNOS Inc.
BROSSARD, Québec, Feb. 23, 2024 (GLOBE NEWSWIRE) -- In accordance with regulatory requirements, Diagnos Inc. (“DIAGNOS”, the “Corporation” or the “Issuer”) (TSX Venture: ADK), announces that on...
DIAGNOS recognized as a Top TSX Venture Exchange Company
February 21, 2024 09:00 ET
|
DIAGNOS Inc.
BROSSARD, Quebec, Feb. 21, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS est reconnue comme l'une des meilleures sociétés de la Bourse de croissance TSX
February 21, 2024 09:00 ET
|
DIAGNOS inc.
BROSSARD, Québec, 21 févr. 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), pionnière de la détection précoce des...